GlassScriptPhysician profile
Jessica Hals
NPI 1013955095
$11,744.13
in general payments reported to CMS, 2019-2025
79 companies · $1,499 in 2025
The $1,499 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,315 · 2021: $50.21 · 2022: $2,787 · 2023: $4,358 · 2024: $1,736 · 2025: $1,499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,375 · Education: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,374.69 |
| Education | $217.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $791.63 | 2019-2025 | Calquence, Tagrisso, Enhertu |
| Novartis Pharmaceuticals Corporation | $722.11 | 2019-2025 | |
| Janssen Biotech, INC. | $718.35 | 2019-2025 | Darzalex, Tecvayli, Erleada |
| Merck Sharp & Dohme LLC | $584.73 | 2019-2025 | Keytruda, Lynparza |
| Pfizer INC. | $523.47 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $518.57 | 2019-2025 | Opdivo, Opdualag |
| Daiichi Sankyo INC. | $366.65 | 2022-2025 | Enhertu, Injectafer, Datroway |
| Genentech USA, INC. | $351.11 | 2019-2025 | Lunsumio, Polivy, Venclexta |
| Astellas Pharma US INC | $317.53 | 2019-2024 | Xospata, Xtandi, Padcev |
| Amgen INC. | $302.30 | 2019-2023 | Kyprolis, Nplate, Xgeva |
| Karyopharm Therapeutics INC. | $295.58 | 2022-2024 | Xpovio |
| Glaxosmithkline, LLC. | $289.93 | 2022-2025 | Ojjaara, Jemperli, Zejula |
| Eisai INC. | $287.51 | 2019-2025 | |
| Aveo Pharmaceuticals, INC. | $279.19 | 2022-2025 | Fotivda |
| Lilly USA, LLC | $262.20 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
Show all 79 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $256.54 | 2019-2024 | Reblozyl, Pomalyst |
| Genzyme Corporation | $249.35 | 2019-2025 | |
| Incyte Corporation | $231.01 | 2019-2025 | Jakafi, Monjuvi |
| Abbvie INC. | $229.89 | 2019-2025 | |
| Seagen INC. | $212.84 | 2019-2023 | Tukysa, Adcetris |
| Sobi, INC | $208.50 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $183.82 | 2019-2025 | |
| US Oncology Corporate, INC. | $179.30 | 2023 | |
| Jazz Pharmaceuticals INC. | $169.33 | 2019-2024 | |
| Ipsen Biopharmaceuticals, INC | $169.26 | 2019-2025 | Onivyde, Somatuline Depot |
| Takeda Pharmaceuticals U.S.A., INC. | $164.63 | 2019-2024 | Fruzaqla, Iclusig, Ninlaro |
| Beigene USA, INC. | $125.32 | 2022-2025 | Brukinsa |
| Pacira Pharmaceuticals Incorporated | $124.97 | 2023 | Exparel |
| Puma Biotechnology, INC. | $123.94 | 2019-2024 | |
| Pharmacosmos Therapeutics INC. | $111.72 | 2022-2025 | Monoferric |
| Pharmaessentia USA Corporation | $109.52 | 2022-2025 | Besremi |
| Taiho Oncology, INC. | $106.25 | 2019-2024 | |
| Adc Therapeutics America, INC. | $103.32 | 2022-2025 | |
| Array Biopharma INC | $99.84 | 2022-2025 | Braftovi, Mektovi, Tukysa |
| Intuitive Surgical, INC. | $91.98 | 2023 | Da Vinci Surgical System |
| Regeneron Healthcare Solutions, INC. | $91.15 | 2019-2024 | Libtayo |
| Exelixis INC. | $89.90 | 2022-2025 | Cabometyx |
| Morphosys, US INC. | $82.06 | 2022-2024 | Monjuvi |
| Tempus Ai, INC | $81.68 | 2024-2025 | Xt Cdx |
| Pharmacyclics LLC, An Abbvie Company | $80.66 | 2019-2023 | Imbruvica |
| Beone Medicines USA, INC. | $78.45 | 2025 | Tevimbra, Brukinsa |
| Gilead Sciences, INC. | $77.05 | 2019-2024 | |
| Tersera Therapeutics LLC | $75.37 | 2022-2023 | Zoladex |
| Emd Serono, INC. | $70.07 | 2019-2024 | Bavencio |
| Caris Mpi, INC. | $66.33 | 2025 | Mi Cancer Seek |
| Erbe USA INC | $65.70 | 2023 | Erbe Cryo2 |
| Rigel Pharmaceuticals, INC. | $62.43 | 2019-2023 | Tavalisse, Rezlidhia |
| Acrotech Biopharma INC. | $61.71 | 2022-2025 | Beleodaq |
| Epizyme, INC. | $61.39 | 2022 | |
| Kite Pharma, INC. | $54.76 | 2023 | Yescarta |
| Agios Pharmaceuticals, INC. | $52.58 | 2023-2024 | Pyrukynd |
| Sumitomo Pharma America, INC. | $50.07 | 2023-2024 | Orgovyx |
| Coherus Oncology, INC. | $45.79 | 2022 | |
| Cti Biopharma Corp. | $43.28 | 2023 | Vonjo |
| Servier Pharmaceuticals LLC | $40.89 | 2023-2025 | |
| Alexion Pharmaceuticals, INC. | $35.27 | 2023-2024 | Ultomiris |
| Heron Therapeutics, INC. | $35.00 | 2023 | Sustol |
| Kyowa Kirin, INC. | $32.93 | 2022-2023 | Poteligeo |
| Iovance Biotherapeutics, INC. | $32.22 | 2025 | Amtagvi |
| Amneal Pharmaceuticals LLC | $30.99 | 2023-2024 | Neupogen, Neulasta, Avastin |
| Stemline Therapeutics INC. | $30.84 | 2023 | Orserdu |
| Foundation Medicine, INC. | $29.69 | 2022 | |
| Tesaro, INC. | $26.13 | 2019 | |
| Mirati Therapeutics, INC. | $25.82 | 2023 | Krazati |
| Genmab U.S., INC. | $24.55 | 2023 | Epkinly |
| Nestle Healthcare Nutrition INC. | $24.41 | 2022 | |
| Blueprint Medicines Corporation | $24.38 | 2022 | |
| Fennec Pharmaceuticals, INC. | $21.68 | 2024 | Pedmark |
| Sun Pharmaceutical Industries INC. | $20.88 | 2019 | |
| G1 Therapeutics, INC. | $18.36 | 2022 | |
| Verastem, INC. | $17.83 | 2019 | |
| Deciphera Pharmaceuticals INC. | $17.47 | 2022 | |
| Janssen Pharmaceuticals, INC | $16.41 | 2022 | |
| Springworks Therapeutics, INC. | $15.42 | 2024 | Ogsiveo |
| Dova Pharmaceuticals | $15.42 | 2019 | |
| Tolmar, INC. | $15.08 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $13.63 | 2019 | |
| Tg Therapeutics, INC. | $13.37 | 2022 | |
| Shield Therapeutics INC | $12.84 | 2023 | Accrufer |
Drugs and devices associated with these payments
Keytruda $342Xpovio $267Lenvima $230Fotivda $217Calquence $212Enhertu $205Kisqali $205Doptelet $192Darzalex $189Lynparza $174Tukysa $173Imbruvica $163Tecvayli $156Verzenio $155Venclexta $146Opdivo $141Zepzelca $137Xtandi $135Ojjaara $128Exparel $125Brukinsa $124Piqray $120Erleada $120Ibrance $114Onivyde $111Jaypirca $111Monjuvi $107Epkinly $103Orgovyx $100Da Vinci Surgical System $91.98Talvey $91.69Braftovi $88.95Stivarga $88.54Vitrakvi $88.54Jakafi $86.56Lunsumio $79.68Tevimbra $78.45Somatuline Depot $75.32Polivy $66.40Mi Cancer Seek $66.33Erbe Cryo2 $65.70Besremi $64.47Scemblix $64.09Mektovi $63.65Comirnaty $60.66Libtayo $60.37Jemperli $59.76Vonjo $59.44Kyprolis $58.79Talzenna $57.38Pluvicto $55.03Akeega $53.22Pyrukynd $52.58Xt Cdx $52.28Monoferric $52.18Tagrisso $51.38Rezlidhia $50.10Tavalisse $50.10Beleodaq $49.74Injectafer $48.76Zejula $47.81Xospata $47.05Paxlovid $45.66Inqovi $44.50Lonsurf $44.50Retevmo $44.23Columvi $43.22Gazyva $43.22Fruzaqla $42.62Tecentriq $38.75Reblozyl $38.50Yescarta $38.11Jevtana $38.02Pomalyst $36.90Xgeva $35.72Nplate $35.72Wayrilz $35.37Ultomiris $35.27Sustol $35.00Cabometyx $34.79Opdualag $33.47Nubeqa $32.90Balversa $32.45Amtagvi $32.22Padcev $31.58Sarclisa $31.00Neupogen $30.99Neulasta $30.99Avastin $30.99Orserdu $30.84Iclusig $29.99Tasigna $27.42Datroway $27.18Enjaymo $25.86Cablivi $25.86Krazati $25.82Fabhalta $25.48Promacta $25.05Tecentriq Hybreza $23.71Ninlaro $23.71
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Hals listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.